Company / Return on Assets (ROA)
AbCellera Biologics Inc. Return on Assets (ROA) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-10.8%
FY2025
5-year range
-12.0% / 7.7%
FY2021-FY2025
Trend
+9.9%
vs FY2024
Sector context
#81 of 213
Health Care
What the data says
At -10.8%, AbCellera Biologics Inc.'s return on assets (roa) ranks #81 of 213 in the Health Care sector. Return on Assets (ROA) returned to growth in FY2025 after 2 years of decline, reaching -10.8%.
Based on SEC 10-K filings.
-10.8% in FY2025 with a 5-year CAGR of -22.6%.
Declined from -9.8% to -10.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -18.5pp
- 5-Year Change
- -22.6pp
- 10-Year Change
- -
Sector benchmark
#81 of 213 in Health CareTop 38% of 213This company -10.8% Sector average -24.2%
▼
+55.3% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 9.9% year-over-year.
- Currently 13.4pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -10.8% | +9.9% |
| FY2024 | -12.0% | -21.6% |
| FY2023 | -9.8% | -227.5% |
| FY2022 | 7.7% | +4641.2% |
| FY2021 | -0.2% | -101.4% |
| FY2020 | 11.8% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026